REG - Spire Healthcare Grp - AGM Trading Statement

Spire HealthcareAnnouncement

14/05/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250514:nRSN5387Ia&default-theme=true

RNS Number : 5387I  Spire Healthcare Group PLC  14 May 2025

 

Spire Healthcare Group plc

 

('Spire Healthcare', 'the Group' or 'the Company')

 

 

 

14 May 2025

 

Ahead of its Annual General Meeting later today, Spire Healthcare Group plc
(LSE: SPI), a leading independent healthcare group in the UK, issues the
following trading statement for the period 1 January 2025 to 30 April 2025
("the period").

The Board is pleased to confirm that performance in the period has been in
line with our expectations and the 2025 guidance provided. Furthermore, our
on-going transformation programme, which is expected to deliver at least £30m
in efficiencies during FY25, remains on track with benefits weighted towards
the second half of the year.

We confirm, as a business with 100% direct UK revenue exposure, we do not
currently anticipate any material cost or supply chain impacts as a result of
recent tariff announcements.

Spire has also been recently named a founding supplier as part of the
Government's National Strategic Supplier Relationship programme. We look
forward to working with the NHS to build a strong, long term and sustainable
footing for increased NHS commissioning.

Upcoming events

Primary Care roundtable 20 May: Investor and analyst event, hosted by our
Primary Care Executive Management Team. Taking place on 20 May at 9am as a
hybrid event. To attend in-person please contact investors@spirehealthcare.com
(https://spirehealthcare.sharepoint.com/sites/Commercial/Investor%20and%20Public%20Relations/Investor%20Relations/RNS%20-%20non-results/2025/AGM%20trading%20statement/investors@spirehealthcare.com)
or for those who wish to join virtually please register using the following
link and webinar ID 812 2509 3179:
 https://storm-virtual-uk.zoom.us/webinar/register/WN_KjAnWLn5T4KCO-YcZnzlng
(https://storm-virtual-uk.zoom.us/webinar/register/WN_KjAnWLn5T4KCO-YcZnzlng)

 

Notice of interim results 31 July: results for the six-month period ending 30
June 2025 will be announced on Thursday, 31 July 2025. A link to the webcast
will be provided in due course through our website at
https://www.investors.spirehealthcare.com
(https://www.investors.spirehealthcare.com)

 

For further information please contact:

 

 Spire Healthcare:
 investors@spirehealthcare.com (mailto:investors@spirehealthcare.com)
 Amie Gramlick: Director of Investor Relations & Commercial Finance
 Instinctif Partners:
 spire@instinctif.com (mailto:spire@instinctif.com)
 Julian Walker

Tim Pearson

 

Registered Office and Head Office:

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

 

About Spire Healthcare

Spire Healthcare (https://www.spirehealthcare.com/) is a leading independent
healthcare group in the United Kingdom, running 38 hospitals and over 50
clinics, medical centres and consulting rooms across England, Wales and
Scotland. It operates a network of private GPs and provides occupational
health services to over 800 corporate clients. Working in partnership with
over 8,600 experienced consultants, Spire Healthcare delivered tailored,
personalised care to over 1 million inpatients, outpatients and daycase
patients, and occupational health programme clients, in 2023, and is the
leading private provider, by volume, of knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
operations in the United Kingdom. It also delivers a range of private and NHS
mental health, musculoskeletal and dermatological services under the Vita
Health Group brand.

Spire Healthcare's well-located and scalable hospitals have delivered
successful and award-winning outcomes, positioning the group well with
patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI')
providers. 98% of Spire Healthcare's inspected locations are rated 'Good,'
'Outstanding' or the equivalent by health inspectors in England, Wales and
Scotland.

Spire Healthcare is listed on the London Stock Exchange and is a member of the
FTSE 250.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTUOORRVVUVAUR